Genetic analysis of intellectual disability and autism.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
09 11 2020
09 11 2020
Historique:
received:
28
09
2020
accepted:
23
10
2020
entrez:
10
11
2020
pubmed:
11
11
2020
medline:
29
6
2021
Statut:
epublish
Résumé
Intellectual disability (ID) and autism spectrum disorders (ASD) are neurodevelopmental conditions that often co-exist and affect children from birth, impacting on their cognition and adaptive behaviour. Social interaction and communication ability are also severely impaired in ASD. Almost 1-3% of the population is affected and it has been estimated that approximately 30% of intellectual disability and autism is caused by genetic factors. The aim of this review is to summarize monogenic conditions characterized by intellectual disability and/or autism for which the causative genes have been identified. We identified monogenic ID/ASD conditions through PubMed and other NCBI databases. Many such genes are located on the X chromosome (>150 out of 900 X-linked protein-coding genes), but at least 2000 human genes are estimated to be involved in ID/ASD. We selected 174 genes (64 X-linked and 110 autosomal) for an NGS panel in order to screen patients with ID and/or ASD, after fragile X syndrome and significant Copy Number Variants have been excluded. Accurate clinical and genetic diagnosis is required for precise treatment of these disorders, but due to their genetic heterogeneity, most cases remain undiagnosed. Next generation sequencing technologies have greatly enhanced the identification of new genes associated with intellectual disability and autism, ultimately leading to the development of better treatment options.
Sections du résumé
BACKGROUND AND AIM
Intellectual disability (ID) and autism spectrum disorders (ASD) are neurodevelopmental conditions that often co-exist and affect children from birth, impacting on their cognition and adaptive behaviour. Social interaction and communication ability are also severely impaired in ASD. Almost 1-3% of the population is affected and it has been estimated that approximately 30% of intellectual disability and autism is caused by genetic factors. The aim of this review is to summarize monogenic conditions characterized by intellectual disability and/or autism for which the causative genes have been identified.
METHODS AND RESULTS
We identified monogenic ID/ASD conditions through PubMed and other NCBI databases. Many such genes are located on the X chromosome (>150 out of 900 X-linked protein-coding genes), but at least 2000 human genes are estimated to be involved in ID/ASD. We selected 174 genes (64 X-linked and 110 autosomal) for an NGS panel in order to screen patients with ID and/or ASD, after fragile X syndrome and significant Copy Number Variants have been excluded.
CONCLUSIONS
Accurate clinical and genetic diagnosis is required for precise treatment of these disorders, but due to their genetic heterogeneity, most cases remain undiagnosed. Next generation sequencing technologies have greatly enhanced the identification of new genes associated with intellectual disability and autism, ultimately leading to the development of better treatment options.
Identifiants
pubmed: 33170170
doi: 10.23750/abm.v91i13-S.10684
pmc: PMC8023126
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2020003Références
Nat Genet. 2010 Dec;42(12):1109-12
pubmed: 21076407
Am J Hum Genet. 2014 May 1;94(5):677-94
pubmed: 24768552
J Med Genet. 2014 Nov;51(11):724-36
pubmed: 25167861
Curr Opin Genet Dev. 2008 Jun;18(3):241-50
pubmed: 18694825
Mol Cell Probes. 2019 Jun;45:84-88
pubmed: 30914295
Cold Spring Harb Perspect Med. 2017 Mar 1;7(3):
pubmed: 28250017
BMC Med Genet. 2019 May 14;20(1):80
pubmed: 31088393
Am J Hum Genet. 2011 Mar 11;88(3):306-16
pubmed: 21376300
Am J Hum Genet. 2016 Jan 7;98(1):149-64
pubmed: 26748517
Mol Psychiatry. 2019 Jul;24(7):1027-1039
pubmed: 29302074
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:161-74
pubmed: 24709068
Open Biol. 2019 Jun 28;9(6):180265
pubmed: 31185809
F1000Res. 2016 Apr 07;5:
pubmed: 27127621
Hum Mutat. 2019 Sep;40(9):1346-1363
pubmed: 31209962
Am J Med Genet A. 2013 Nov;161A(11):2797-808
pubmed: 24123753
Mol Genet Genomics. 2016 Apr;291(2):513-30
pubmed: 26481646
Genet Med. 2020 Jun;22(6):1036-1039
pubmed: 32152462
Cold Spring Harb Perspect Med. 2014 Jul 24;4(9):a008581
pubmed: 25059740
Am J Med Genet A. 2011 May;155A(5):974-5
pubmed: 21465654
Am J Hum Genet. 2010 May 14;86(5):749-64
pubmed: 20466091
Am J Hum Genet. 2013 Aug 8;93(2):368-83
pubmed: 23871722
Trends Neurosci. 2014 Feb;37(2):95-105
pubmed: 24387789
Eur J Hum Genet. 2008 Apr;16(4):422-34
pubmed: 18197188
J Child Psychol Psychiatry. 2011 Jan;52(1):91-9
pubmed: 20649912
Clin Genet. 2020 Nov;98(5):433-444
pubmed: 32335911
Clin Exp Pediatr. 2020 Jun;63(6):195-202
pubmed: 32024334
Pharmacol Ther. 2018 Oct;190:91-104
pubmed: 29763648
Hum Mutat. 2015 Dec;36(12):1197-204
pubmed: 26350204
NCHS Data Brief. 2017 Nov;(291):1-8
pubmed: 29235982